淋巴结采集套件与提高意识对肺癌手术质量及结局的比较效果
该研究基于2009至2020年人群为基础的阶梯式整群非随机实施研究,比较提高淋巴结分期质量意识(HA)与淋巴结采集套件对肺癌根治性切除术质量及结局的影响。共纳入3734例切除术,套件组在pNX率、纵隔淋巴结未检查率及NCCN、CoC、IASLC标准达成上均显著优于HA组和基线组(p<0.001),两种干预均显著改善生存(p<0.0001),但套件更有效。
要点
- 淋巴结采集套件较提高意识更显著改善肺癌手术淋巴结分期质量。
- 套件组pNX率0%、纵隔淋巴结未检查率1%,远低于基线及HA组。
- 两种干预均与基线相比显著提高生存率(p<0.0001)。
核心结论
- 提高意识或使用套件均显著改善手术质量与结局,但套件更有效。
研究设计与样本
- 2009至2020年基于人群的非随机阶梯式整群实施研究,纳入3734例根治性肺癌切除术。
- 按干预分为基线(39%)、套件(40%)和HA(21%)三个亚队列。
主要发现
- pNX率:基线11%,套件0%,HA 9%。
- 纵隔淋巴结未检查率:基线27%,套件1%,HA 22%。
- CoC基准达成率:基线14%,套件77%,HA 30%。
- IASLC完全切除定义达成率:基线11%,套件58%,HA 24%。
- NCCN达成率:基线23%,套件79%,HA 35%(除pNX基线vs HA外,所有p<0.001)。
关键数值与推荐
- pNX率:基线11%,套件0%,HA 9%。
- 纵隔淋巴结未检查率:基线27%,套件1%,HA 22%。
- CoC基准达成率:基线14%,套件77%,HA 30%。
- IASLC完全切除达成率:基线11%,套件58%,HA 24%。
- NCCN达成率:基线23%,套件79%,HA 35%(除pNX基线vs HA外,所有p<0.001)。
临床怎么用
- 在肺癌根治性切除术中采用淋巴结采集套件可显著提高淋巴结分期质量。
- 仅提高意识对改善淋巴结检查质量效果有限,套件更具推广价值。
局限性
- 研究为非随机阶梯式整群设计,可能存在混杂偏倚。
- 原文未报告套件与HA组间直接比较的统计检验结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The adverse prognostic impact of poor pathologic nodal staging has stimulated efforts to heighten awareness of the problem through guidelines, without guidance on processes to overcome it. We compared heightened awareness (HA) of nodal staging quality versus a lymph node collection kit. METHODS: We categorized curative-intent lung cancer resections from 2009 to 2020 in a population-based, nonrandomized stepped-wedge implementation study of both interventions, into preintervention baseline, HA, and kit subcohorts. We used differences in proportion and hazard ratios across the subcohorts to estimate the effect of the interventions on poor quality (nonexamination of nodes [pNX] or nonexamination of mediastinal lymph nodes) and attainment of quality recommendations of the National Comprehensive Cancer Network, the Commission on Cancer, and the proposed complete resection definition of the International Association for the Study of Lung Cancer across the three cohorts. RESULTS: Of 3734 resections, 39% were preintervention, 40% kit, and 21% HA cases. Cohort proportions were the following: pNX, 11% (baseline) versus 0% (kit) versus 9% (HA); nonexamination of mediastinal lymph nodes, 27% versus 1% versus 22%; Commission on Cancer benchmark attainment, 14% versus 77% versus 30%; International Association for the Study of Lung Cancer-defined complete resection, 11% versus 58% versus 24%; National Comprehensive Cancer Network attainment, 23% versus 79% versus 35% (p < 0.001 for all, except pNX rate baseline versus HA). Survival rate was significantly higher for both interventions compared with baseline (p < 0.0001). CONCLUSIONS: Resections with HA or the kit significantly improved surgical quality and outcomes, but the kit was more effective. We propose to conduct a prospective, institutional cluster-randomized clinical trial comparing both interventions.
引用
- Ray MA, Fehnel C, Akinbobola O, et al. Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes. J Thorac Oncol. 2021. PMID: 33588112. doi:10.1016/j.jtho.2021.01.1618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。